This study examined whether sucrose, fructose, aspartame and saccharin influences the association between obesity and glucose tolerance in 2856 adults from the NHANES III survey.
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Introduction
Type 2 diabetes mellitus is a metabolic disorder characterized by glucose intolerance and insulin resistance leading to hyperglycemia (Kerner 2014) . Obesity has been strongly linked with type 2 diabetes, and nearly 90% of individuals with diabetes have overweight or obesity (Saydah 2014) . Sugar consumption is one of the common suspected culprits for the rise in obesity and may contribute to the development of type 2 diabetes (Hu 2010). Consequently, artificial sweeteners are commonly consumed by individuals with obesity and type 2 diabetes as they are thought to lower the caloric content and blood glucose response. However, in animal models, use of artificial sweeteners may also increase weight gain over time (Swithers 2013) , and may promote glucose intolerance through the altered function and composition of intestinal microbiota (Suez 2014). In humans, there is very little evidence that artificial sweeteners promote glucose intolerance and there are only a few long-term studies on the use of sweeteners and weight change, and studies that report metabolic differences with intervention do not adjust for concurrent changes in body weight (Wiebe 2011) . Further, there is no report on whether natural sugars or artificial sweeteners have an effect on diabetes risk independent of obesity.
Thus, the aim of this study is to determine whether natural sugars and artificial sweetener consumption modifies the association between glucose tolerance, insulin resistance, fasting glucose and BMI.
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Methods
Participants
The Third National Health and Nutrition Examination Survey (NHANES III) is a nationally representative cross-sectional survey conducted in the United States between 1988 and 1994 in 33,994 persons, aged 2 months and older. Participants were examined at home and at a mobile exam center for various markers of health, including demographics, medical history, dietary practices, blood profile and anthropometrics (CDC 1994; CDC 1996) . Participants gave informed written consent, and the study protocol was approved by the National Center for Health Statistics.
Secondary analyses conducted for this study utilized 2856 adults with complete data for oral glucose tolerance, weight, height and diet, and who were not taking medications for diabetes. Age, sex, education, ethnicity (White, or non-White), and smoking status (never, current and former) were self-reported by questionnaire. Body mass index (BMI) was calculated using measured height and weight.
Metabolic Measures
The oral glucose tolerance test (OGTT) was conducted at the mobile examination center and was limited to a subset of individuals aged 40-74 years old without previously diagnosed type 2 diabetes and who were not taking insulin, after an overnight fast (>8 hours). Blood was drawn from the antecubital vein by a trained phlebotomist according to a standardized protocol.
Participants received a 75-g glucose-equivalent oral glucose challenge and a second blood sample was drawn 2 hours later. Fasting and 2-h plasma glucose levels were measured by a hexokinase enzymatic reference method (Roche Cobas Mira, Indianapolis, IN). Homeostatic D r a f t model assessment of insulin resistance (HOMA-IR) was calculated by dividing the product of fasting plasma glucose (mmol/L) and insulin (mU/L) by 22.5.
Dietary Intake
At the mobile examination center, two dietary interviewers administered the dietary questionnaire and recorded the types and amounts of all foods and beverages consumed by the participant in the last 24 hours. Data on specific sugar (sucrose and fructose) and artificial sweetener (aspartame and saccharin) intake was available from The Total Nutrient Intake File.
Individuals were classified as consumers or non-consumers of artificial sweeteners (yes or no) and by high and low natural sugar intake (top 80% versus bottom 20%).
Statistical analysis
Participant characteristics are presented as mean (SE) or frequencies. Differences in the relationship between glucose tolerance, fasting glucose and insulin resistance (outcomes) with BMI (continuous correlate) by sugar/sweetener intake (categorical) were assessed using elementwise regression (proc surveyreg which uses generalized least squares estimation) with examination of BMI by sugar/sweetener interaction and main effects with adjustment for potential confounders (age, sex, smoking status, education, and ethnicity -fixed effects). All statistical analyses were performed using SAS v9.4 survey procedures weighted to be representative of the U.S. population. Statistical significance was set at alpha <0.05.
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Results
Individuals consuming artificial sweeteners (aspartame or saccharin) had a subtly higher BMI (28 versus 27 kg/m 2 ), and were more likely to be female (Table 1, P<0.05). Those consuming high sucrose, high fructose and no aspartame were significantly younger, while those consuming saccharin were significantly older than those who did not (P<0.05). There were no differences in glucose tolerance, HOMA-IR or fasting plasma glucose between those consuming high sugars or artificial sweeteners and those who did not.
The interaction and main effects of BMI and sugars and sweeteners are presented in 
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Discussion
The results of the current study illustrate that aspartame consumption is associated with augmented obesity-related deteriorations in glucose tolerance and fasting glucose. Thus, more research is needed to better understand the weight management benefits of artificial sweetener consumption over natural sugars against the potential increased diabetes risk, particularly for those with obesity.
Due to the potential health dangers and weight implications of natural sugars, use of lowcalorie sweeteners has grown in popularity (Sylvetsky 2012), and many newer artificial sweeteners are now consumed beyond those examined here (Mayo Clinic 2016). Use of lowcalorie sweetener substitutes are reported to be associated with clear reductions in caloric intake and modest reductions in body weight (Miller 2014 (Sakurai 2014 ). In the current study, we do not observe an independent effect of sucrose consumption on glucose tolerance independent of BMI, supporting the notion that it is calories as opposed to sugar that may be leading to obesity and increased diabetes risk (Hu and Malik 2010).
In humans, fructose consumption is thought to be related with increased visceral adiposity and dyslipidemia even without weight gain (Maersk 2012). Although visceral adiposity and dyslipidemia are both associated with glucose intolerance (Borel 2014; Boden 2002), we did not observe that high fructose consumption has an independent effect on glucose tolerance. This may indicate that our cut-off used to denote 'high' fructose consumption may not have been sufficiently high, or that the effects of fructose on visceral adiposity were not sufficiently large to have a negative impact on glucose tolerance independent of BMI.
The results of this study are based on 24-hour self-reported diet and may not be reflective of chronic intake patterns. However, it is unclear whether chronic ingestion is needed to result in changes in glucose tolerance, or if these results also apply to the newer artificial sweeteners that are now currently used. Further, we are unsure if there is a dose-response relationship between sweeteners and changes in glucose tolerance, and the cross-sectional results observed here may be subject to reverse causation. Finally, due to the multiple associations examined, there is the possibility that the observations here are due to chance. Nevertheless, these results are weighted to be representative of the U.S population and illustrate on a population level that sweetener D r a f t consumption may have clinically relevant impacts on glucose tolerance and type 2 diabetes risk independent of BMI.
In conclusion, aspartame artificial sweetener consumptions may be associated with greater glucose intolerance, particularly for those with obesity. Future research is needed to determine whether from an obesity and diabetes perspective, it may be prudent to limit all sweetener consumption.
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